181 related articles for article (PubMed ID: 19177354)
41. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
42. Development of novel molecular probes of the Rio1 atypical protein kinase.
Mielecki M; Krawiec K; Kiburu I; Grzelak K; Zagórski W; Kierdaszuk B; Kowa K; Fokt I; Szymanski S; Swierk P; Szeja W; Priebe W; Lesyng B; LaRonde-LeBlanc N
Biochim Biophys Acta; 2013 Jul; 1834(7):1292-301. PubMed ID: 23523885
[TBL] [Abstract][Full Text] [Related]
43. Role of CHK2 in cancer development.
Perona R; Moncho-Amor V; Machado-Pinilla R; Belda-Iniesta C; Sánchez Pérez I
Clin Transl Oncol; 2008 Sep; 10(9):538-42. PubMed ID: 18796370
[TBL] [Abstract][Full Text] [Related]
44. The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.
Bahassi EM; Ovesen JL; Riesenberg AL; Bernstein WZ; Hasty PE; Stambrook PJ
Oncogene; 2008 Jun; 27(28):3977-85. PubMed ID: 18317453
[TBL] [Abstract][Full Text] [Related]
45. Chk2 kinase is required for methylglyoxal-induced G2/M cell-cycle checkpoint arrest: implication of cell-cycle checkpoint regulation in diabetic oxidative stress signaling.
Kani S; Nakayama E; Yoda A; Onishi N; Sougawa N; Hazaka Y; Umeda T; Takeda K; Ichijo H; Hamada Y; Minami Y
Genes Cells; 2007 Aug; 12(8):919-28. PubMed ID: 17663721
[TBL] [Abstract][Full Text] [Related]
46. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
[TBL] [Abstract][Full Text] [Related]
47. The Chk2 protein kinase.
Ahn J; Urist M; Prives C
DNA Repair (Amst); 2004; 3(8-9):1039-47. PubMed ID: 15279791
[TBL] [Abstract][Full Text] [Related]
48. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.
Reinhardt HC; Yaffe MB
Curr Opin Cell Biol; 2009 Apr; 21(2):245-55. PubMed ID: 19230643
[TBL] [Abstract][Full Text] [Related]
49. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen Y; Poon RY
Front Biosci; 2008 May; 13():5016-29. PubMed ID: 18508566
[TBL] [Abstract][Full Text] [Related]
50. Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125.
Chu ML; Chavas LM; Douglas KT; Eyers PA; Tabernero L
J Biol Chem; 2008 Aug; 283(31):21495-500. PubMed ID: 18480048
[TBL] [Abstract][Full Text] [Related]
51. Crystal structure of human RIOK2 bound to a specific inhibitor.
Wang J; Varin T; Vieth M; Elkins JM
Open Biol; 2019 Apr; 9(4):190037. PubMed ID: 30991936
[TBL] [Abstract][Full Text] [Related]
52. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
53. Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways.
Gaul L; Mandl-Weber S; Baumann P; Emmerich B; Schmidmaier R
J Cancer Res Clin Oncol; 2008 Feb; 134(2):245-53. PubMed ID: 17653574
[TBL] [Abstract][Full Text] [Related]
54. Structure of the Brachydanio rerio Polo-like kinase 1 (Plk1) catalytic domain in complex with an extended inhibitor targeting the adaptive pocket of the enzyme.
Elling RA; Fucini RV; Hanan EJ; Barr KJ; Zhu J; Paulvannan K; Yang W; Romanowski MJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Aug; 64(Pt 8):686-91. PubMed ID: 18678933
[TBL] [Abstract][Full Text] [Related]
55. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
56. Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells.
Takagaki K; Katsuma S; Kaminishi Y; Horio T; Tanaka T; Ohgi T; Yano J
Genes Cells; 2005 Feb; 10(2):97-106. PubMed ID: 15676021
[TBL] [Abstract][Full Text] [Related]
57. A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage.
Carlessi L; Buscemi G; Fontanella E; Delia D
Biochim Biophys Acta; 2010 Oct; 1803(10):1213-23. PubMed ID: 20599567
[TBL] [Abstract][Full Text] [Related]
58. Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis.
Wu X; Chen J
J Biol Chem; 2003 Sep; 278(38):36163-8. PubMed ID: 12855706
[TBL] [Abstract][Full Text] [Related]
59. 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition.
Meng S; Arbit T; Veeriah S; Mellinghoff IK; Fang F; Vivanco I; Rohle D; Chan TA
Cell Cycle; 2009 Jul; 8(14):2238-46. PubMed ID: 19502805
[TBL] [Abstract][Full Text] [Related]
60. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
